Two-year-old Georgia Bruchmiller, an East Texas toddler born profoundly deaf, has had her hearing restored following a revolutionary gene therapy surgery performed on March 10 of this year at Nemours Children’s Hospital in Orlando, Florida. The one-time, eight-hour procedure involved infusing a manufactured gene directly into her inner ear, enabling her body to begin processing sound. This groundbreaking treatment, which resulted from a pioneering clinical trial, means Georgia can now respond to sounds like planes overhead and claps, a significant change in her life just five months post-surgery. The drug used, known as Otarmeni, received FDA approval in April, one month after her operation.
Georgia's parents, Sara and Clint Bruchmiller, had no family history of hearing loss and were surprised when their daughter was born profoundly deaf. After exploring multiple medical centers, they were consistently advised that cochlear implants were the only solution. However, the Bruchmillers sought further options, leading them to pursue genetic testing. This testing revealed Georgia’s profound deafness was caused by a rare OTOF gene mutation, which affects approximately 200,000 people worldwide and prevents the body from producing the vital protein otoferlin.
The discovery of the OTOF gene mutation opened the door for Georgia to be accepted into the gene therapy clinical trial at Nemours Children’s Hospital. While clinical trials indicated major improvements for 80 percent of children and normal hearing for nearly half, the decision to enroll was initially met with hesitation by the parents. Despite their doubts, Sara Bruchmiller stated, “As a mom, that’s what you want to do for your children. You want to find every single possible option.”
The family's commitment to Georgia’s care began in December 2025, involving extensive travel between Texas and Florida and navigating significant delays. Both parents ultimately lost their jobs during the process to ensure Georgia’s treatment remained on track. Following the surgery, the family remained in Orlando for nearly eight weeks to safeguard Georgia’s health and manage travel. Sara Bruchmiller expressed immense gratitude for pushing through the challenges, reflecting on how their pursuit of a cure transformed Georgia's world. The Bruchmillers are now advocating for widespread genetic testing for newborns, believing it to be the crucial step that saved their daughter's hearing.
